Myriad Genetics Inc (MYGN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
398,859,000
EV to revenue ratio (TTM)
0.523
EV to ebitda
-23.47
Financial Performance
Revenue (TTM)
806,600,000
Gross profit (TTM)
555,200,000
EBITDA
-40,300,000
Profitability
Operating margin (TTM)
-20.40%
Profit margin
-14.00%
Return on assets (TTM)
-8.60%
Return on equity (TTM)
-32.50%
Per Share Metrics
Revenue per share (TTM)
8.61
EPS
-1.18
Diluted EPS (TTM)
-1.18
Book value
3.18
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
54.05
PEG ratio
1.4
Price to sales ratio (TTM)
0.494
Price to book ratio (TTM)
1.262
Growth
Quarterly earnings growth (YoY)
-10.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
1
Hold
5
Sell
1
Strong sell
1
Risk & Volatility
Beta
1.682